Antiproliferative and Antitumour Effect of Nongenotoxic Silver Nanoparticles on Melanoma Models; Oxidative Medicine and Cellular Longevity; Vol. 2019

Detaylı Bibliyografya
Parent link:Oxidative Medicine and Cellular Longevity
Vol. 2019.— 2019.— [4528241, 12 p.]
Müşterek Yazar: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)
Diğer Yazarlar: Valenzuela-Salas L. M. Lucia, Giron-Vazquez N., Garcia-Ramos J. C. Juan Carlos, Torres-Bugari O. Olivia, Gomez C. Claudia, Pestryakov A. N. Aleksey Nikolaevich, Villarreal-Gomez L. Luis, Toledano-Magana Ya. Yanis, Bogdanchikova N. Nina
Özet:Title screen
During the last 3 decades, there has been a slow advance to obtain new treatments for malignant melanoma that improve patient survival. In this work, we present a systematic study focused on the antiproliferative and antitumour effect of AgNPs. These nanoparticles are fully characterized, are coated with polyvinylpyrrolidone (PVP), and have an average size of and a metallic silver content of 1.2% wt. Main changes on cell viability, induction of apoptosis and necrosis, and ROS generation were found on B16-F10 cells after six hours of exposure to AgNPs () or Cisplatin (). Despite the similar response for both AgNPs and Cisplatin on antiproliferative potency (cellular viability of and ) and ROS production ( and ), significantly different cell death pathways were triggered. While AgNPs induce only apoptosis (), Cisplatin induces apoptosis and necrosis at the same rate ( and , respectively). In addition to their antiproliferative activity, in vivo experiments showed that treatments of 3, 6, and 12 mg/kg of AgNPs elicit a survival rate almost 4 times higher () compared with the survival rate obtained with Cisplatin (2 mg/kg). Furthermore, the survivor mice treated with AgNPs do not show genotoxic damage determined by micronuclei frequency quantification on peripheral blood cells. These results exhibit the remarkable antitumour activity of a nongenotoxic AgNP formulation and constitute the first advance toward the application of these AgNPs for melanoma treatment, which could considerably reduce adverse effects provoked by currently applied chemotherapeutics.
Dil:İngilizce
Baskı/Yayın Bilgisi: 2019
Konular:
Online Erişim:https://doi.org/10.1155/2019/4528241
Materyal Türü: MixedMaterials Elektronik Kitap Bölümü
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=661244

MARC

LEADER 00000naa0a2200000 4500
001 661244
005 20250414143636.0
035 |a (RuTPU)RU\TPU\network\31513 
035 |a RU\TPU\network\28947 
090 |a 661244 
100 |a 20191126d2019 k||y0rusy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Antiproliferative and Antitumour Effect of Nongenotoxic Silver Nanoparticles on Melanoma Models  |f L. M. Valenzuela-Salas [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 56 tit.] 
330 |a During the last 3 decades, there has been a slow advance to obtain new treatments for malignant melanoma that improve patient survival. In this work, we present a systematic study focused on the antiproliferative and antitumour effect of AgNPs. These nanoparticles are fully characterized, are coated with polyvinylpyrrolidone (PVP), and have an average size of and a metallic silver content of 1.2% wt. Main changes on cell viability, induction of apoptosis and necrosis, and ROS generation were found on B16-F10 cells after six hours of exposure to AgNPs () or Cisplatin (). Despite the similar response for both AgNPs and Cisplatin on antiproliferative potency (cellular viability of and ) and ROS production ( and ), significantly different cell death pathways were triggered. While AgNPs induce only apoptosis (), Cisplatin induces apoptosis and necrosis at the same rate ( and , respectively). In addition to their antiproliferative activity, in vivo experiments showed that treatments of 3, 6, and 12 mg/kg of AgNPs elicit a survival rate almost 4 times higher () compared with the survival rate obtained with Cisplatin (2 mg/kg). Furthermore, the survivor mice treated with AgNPs do not show genotoxic damage determined by micronuclei frequency quantification on peripheral blood cells. These results exhibit the remarkable antitumour activity of a nongenotoxic AgNP formulation and constitute the first advance toward the application of these AgNPs for melanoma treatment, which could considerably reduce adverse effects provoked by currently applied chemotherapeutics. 
461 |t Oxidative Medicine and Cellular Longevity 
463 |t Vol. 2019  |v [4528241, 12 p.]  |d 2019 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a противоопухолевые свойства 
610 1 |a наночастицы 
610 1 |a серебро 
610 1 |a моделирование 
610 1 |a меланома 
701 1 |a Valenzuela-Salas  |b L. M.  |g Lucia 
701 1 |a Giron-Vazquez  |b N. 
701 1 |a Garcia-Ramos  |b J. C.  |g Juan Carlos 
701 1 |a Torres-Bugari  |b O.  |g Olivia 
701 1 |a Gomez  |b C.  |g Claudia 
701 1 |a Pestryakov  |b A. N.  |c Chemist  |c Professor of Tomsk Polytechnic University, Doctor of Chemical Science  |f 1963-  |g Aleksey Nikolaevich  |3 (RuTPU)RU\TPU\pers\30471  |9 14796 
701 1 |a Villarreal-Gomez  |b L.  |g Luis 
701 1 |a Toledano-Magana  |b Ya.  |g Yanis 
701 1 |a Bogdanchikova  |b N.  |g Nina 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537 
801 2 |a RU  |b 63413507  |c 20191126  |g RCR 
850 |a 63413507 
856 4 |u https://doi.org/10.1155/2019/4528241 
942 |c CF